Trial
NCT01555632
Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Nebraska
Collaborators
National Cancer Institute (NCI)
Condition
Recurrent Prostate Cancer
Intervention
atorvastatin calcium
Why stopped
Other more favorable treatments are now available.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-14